Where does Kabushiki Kaisha Dnaform rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Kabushiki Kaisha Dnaform ranks #32,209 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Kabushiki Kaisha Dnaform hold?

Kabushiki Kaisha Dnaform holds 8 US utility patents granted between 2016 and 2022, spanning 7 technology areas.

What is Kabushiki Kaisha Dnaform's Innovation Score?

Kabushiki Kaisha Dnaform has an Innovation Score of 30.1 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Kabushiki Kaisha Dnaform's patent grant rate increasing or decreasing?

Kabushiki Kaisha Dnaform's recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Kabushiki Kaisha Dnaform's patents?

Kabushiki Kaisha Dnaform's patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Kabushiki Kaisha Dnaform patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Kabushiki Kaisha Dnaform

Q: What technology areas does Kabushiki Kaisha Dnaform focus on?

Kabushiki Kaisha Dnaform's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 8 patents. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Kabushiki ranks #32,209 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.

#32,209
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.1/100): 18.3
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32209 · Foreign Corporation #32,209 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,209/49,997
PHOTO-FINISH K-
CPC-NARROW C12Q · 7 areas
INNOV-THIN 30.1/100
CLAIMS-RICH 18.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: K-Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Dnaform · this assignee

30
3D Lighting… · lowest

7

What this shows Kabushiki's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Kabushiki's grants concentrate

Kabushiki Kaisha Dnaform is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2016. By volume, Kabushiki sits between K-technology USA, Inc. and Kairish Innotech Private Ltd..

Kabushiki's three-year grant acceleration

Kabushiki Kaisha Dnaform shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

K-technology USA

8
K-

8
K L Kaschier- UND…

8
Kaarya

8
Kabushiki Kaisya…

8
Kaia Health Softw…

8
Kaijet Technology…

8
Kairish Innotech…

8
Dnaform ◀

8

What this shows Kabushiki holds 8 patents at rank #32,197, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Kabushiki

By rank, the assignees closest to #32,197 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Kabushiki's primary technology class.

Kabushiki's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Kabushiki Kaisha Dnaform patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	12.5%
2017	1	12.5%
2018	2	25.0%
2019	2	25.0%
2020	1	12.5%
2022	1	12.5%

Which technologies does Kabushiki Kaisha Dnaform patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#32,209

of 49,997 tracked assignees

Innovation Score

30.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Kabushiki Kaisha Dnaform's patent record in context - here's where to go next.

Kabushiki Kaisha Dnaform's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #32,209 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Kabushiki Kaisha Dnaform against K-technology USA, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.